Forum Finance Group’s Editas Medicine EDIT Stock Holding History

Forum Finance Group’s Portfolio EDIT Stock Details EDIT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$7K	Hold	2,500	–	–	﹤0.01%	306
2026 Q1	$5K	Buy	+2,500	New	+$5.29K	﹤0.01%	290

Other funds holding EDIT

TCM

TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ACM

ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return

Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

PBA

Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Forum Finance Group's EDIT Position: Q2 2026 in Review

Forum Finance Group held its Editas Medicine (EDIT) position steady in Q2 2026 at 2,500 shares worth $7K. The position accounts for ﹤0.01% of the portfolio, ranked #306.

Forum Finance Group first reported a position in EDIT in Q1 2026 and has held it in 2 quarters since. 214 funds tracked by Wall St. Rank hold EDIT as of Q2 2026.

Forum Finance Group held 2,500 shares of Editas Medicine worth $7K as of Q2 2026.
Forum Finance Group left its Editas Medicine share count unchanged in Q2 2026.
Editas Medicine made up ﹤0.01% of Forum Finance Group's portfolio in Q2 2026, its #306 holding.
Forum Finance Group first reported a position in Editas Medicine in Q1 2026 and has held it in 2 quarters since.
214 funds tracked by Wall St. Rank held Editas Medicine as of Q2 2026.

Based on Forum Finance Group's 13F filing for Q2 2026, filed 14 Aug 2026.